Consensus is for FY26 revenue $5.44B. Raises FY26 Adjusted EBITDA Excluding Acquired IPR&D to $1.010B-$1.060B from $1.000B-$1.050B.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLCO:
- Bausch + Lomb announces narrative review on certain B vitamins
- Bausch + Lomb reports nearly 725k lbs. of eye care materials recycled
- Bausch + Lomb Wins FDA Clearance for Next-Generation Vitrectomy Cutter and Fluidics Upgrade
- Bausch + Lomb receives FDA 510k clearance for Bi-Blade+
- Bausch + Lomb Rolls Out enVista Envy Premium Intraocular Lens Across Europe